Loading...
XNAS
TRUP
Market cap1.13bUSD
Jul 22, Last price  
24.45USD
1D
-5.42%
1Q
-8.90%
Jan 2017
57.54%
IPO
110.78%
Name

Trupanion Inc

Chart & performance

D1W1MN
XNAS:TRUP chart
P/E
54.88
P/S
0.74
EPS
0.45
Div yield, %
Shrs. gr., 5y
3.97%
Rev. gr., 5y
23.45%
Revenues
1.44b
+11.95%
37,045,00055,530,00083,829,000115,910,000146,963,000188,230,000242,667,000303,956,000383,936,000502,028,000698,991,000905,179,0001,108,605,0001,285,684,0001,439,305,000
Net income
19m
P
-3,919,000-6,410,000-8,175,000-21,177,000-17,205,000-6,896,000-1,503,000-927,000-1,809,000-5,840,000-35,530,000-44,672,000-44,693,000-9,633,00019,433,000
CFO
89m
+85.33%
-112,000-1,543,000-1,023,000-10,801,000-10,425,0005,006,0009,666,00012,680,00016,157,00021,544,0007,458,000-8,000,00018,638,00048,287,00089,488,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Trupanion, Inc., including its various subsidiaries, specializes in offering health insurance for pets, specifically canine and feline companions. This coverage is available to customers through a convenient monthly subscription model across the United States, Canada, Puerto Rico, and Australia. The company strategically divides its operations into two distinct segments: its core Subscription Business and an Other Business division. It caters to a dual clientele, serving both individual pet owners and the broader veterinary community. Founded in 2000, the enterprise initially operated under the name Vetinsurance International, Inc. before officially adopting the Trupanion, Inc. moniker in 2013. Its corporate headquarters are situated in Seattle, Washington.
IPO date
Jul 18, 2014
Employees
1,187
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT